Ocugen Signs OCU400 Licensing Agreement with Roots Pharma
MALVERN, Pa., July 13, 2026 Ocugen announced the signing of a binding term sheet with Roots Pharmaceutical and its...
Advertisement
PharmatrophiX Reports Positive LM11A-31 Alzheimer’s Results
MENLO PARK, California, July 13, 2026 PharmatrophiX, in collaboration with Indiana University School of Medicine, has presented encouraging new...
Longeveron Reports Positive Phase 2a Laromestrocel Data
MIAMI, July 13, 2026 Longeveron announced new analyses from its Phase 2a CLEAR MIND clinical trial demonstrating that its...
Autonomix Secures Canadian Patent for Neural Sensing
THE WOODLANDS, Texas, July 13, 2026 Autonomix Medical announced the grant of Canadian Patent No. 3,158,197, titled “Endoscopic Sympathectomy...
Delonix Bioworks Doses First Participant in DX-104 Trial
SHANGHAI, China, July 13, 2026 Delonix Bioworks, a clinical-stage biotechnology company specializing in genetically engineered bacterial vaccines, has announced...
ANI Reports Positive Phase 4 ILUVIEN Trial Results
PRINCETON, N.J., July 13, 2026 ANI Pharmaceuticals announced positive six-month topline results from the Phase 4, open-label, single-arm SYNCHRONICITY...
Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
Vandria Reports Positive Phase 1 VNA-318 Data
LAUSANNE, Switzerland, July 13, 2026 Vandria announced new Phase 1 clinical data demonstrating that its investigational small molecule VNA-318...
Bristol Myers Squibb NDA for Mezigdomide Accepted by FDA
PRINCETON, New Jersey, July 13, 2026 Bristol Myers Squibb (BMS) has announced that the U.S. Food and Drug Administration...
Agilent Expands Altura HPLC Portfolio for Biotherapeutics
SANTA CLARA, California, USA, July 8, 2026 Agilent Technologies has expanded its Altura High-Performance Liquid Chromatography (HPLC) portfolio with...
Advertisement
